Pharmacologic Enhancement of Bacteriophage-Mediated Gene Transfer and Plasmid DNA-Mediated Gene Transfer in Mammalian Cells
University of Rochester
posted on 07/01/2009
Pharmacologic Enhancement of Bacteriophage-Mediated Gene Transfer and Plasmid DNA-Mediated Gene Transfer in Mammalian Cells
Suggested Uses
This technology proposes enhancing both bacteriophage-mediated gene transfer and plasmid DNA-mediated gene transfer in mammalian cells using pharmacological agents. This is applicable for vaccines as well as other gene transfer needs and as a research tool in the laboratory.
Advantages
These methods are advantageous as they enhance the gene activity achieved with bacteriopage-mediated or plasmid DNA-mediated delivery alone. More efficient gene transfer is possible by co-deliver agents that inhibit the proteosome or endosome acidification and by disrupting cellular microtubules. Additionally this may permit stronger immune responses and greater protein expression.
Detailed Description
This technology proposes enhancing both bacteriophage-mediated gene transfer and plasmid DNA-mediated gene transfer in mammalian cells using pharmacological agents. This is applicable for vaccines as well as other gene transfer needs and as a research tool in the laboratory.
These methods are advantageous as they enhance the gene activity achieved with bacteriopage-mediated or plasmid DNA-mediated delivery alone. More efficient gene transfer is possible by co-deliver agents that inhibit the proteosome or endosome acidification and by disrupting cellular microtubules. Additionally this may permit stronger immune responses and greater protein expression.
File Number: 6-1629
Other Information:
- Refer to: Case # 6-1629
- Lead Innovator: Dr. Stephen Dewhurst
- Case Manager: Harl Tolbert
- Harl_Tolbert@urmc.rochester.edu
This innovation currently is not available for online licensing. Please contact Harl Tolbert at University of Rochester for more information.
Find more innovations
